BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9713242)

  • 1. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract]   [Full Text] [Related]  

  • 2. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava-kava extract in anxiety disorders: an outpatient observational study.
    Scherer J
    Adv Ther; 1998; 15(4):261-9. PubMed ID: 10186945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of panic disorders. Kava-specific extract WS 1490 compared to benzodiazepines].
    Nervenarzt; 1994 Jan; 65(1 Suppl):1-4. PubMed ID: 9218056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety].
    De Leo V; La Marca A; Lanzetta D; Palazzi S; Torricelli M; Facchini C; Morgante G
    Minerva Ginecol; 2000 Jun; 52(6):263-7. PubMed ID: 11085051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with Kava--the root to ocombat stress].
    Müller B; Komorek R
    Wien Med Wochenschr; 1999; 149(8-10):197-201. PubMed ID: 10483680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia.
    Boerner RJ
    Phytother Res; 2001 Nov; 15(7):646-7. PubMed ID: 11746854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava: an herbal sedative.
    Kinder C; Cupp MJ
    Nurse Pract; 1998 Jun; 23(6):14, 156. PubMed ID: 9656257
    [No Abstract]   [Full Text] [Related]  

  • 15. Explanatory attributions of anxiety and recovery in a study of kava.
    Abraham KC; Connor KM; Davidson JR
    J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianxiety activity of Gelsemium sempervirens.
    Dutt V; Dhar VJ; Sharma A
    Pharm Biol; 2010 Oct; 48(10):1091-6. PubMed ID: 20860436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.